Nigeria has enough COVID-19 Vaccines to go round, Health Minister

Yusuf Bello| Nigeria’s health minister, Dr. Osagie Ehanire on Friday said that the COVID-19 vaccine is more than enough to go round for Nigerians.

Dr. Ehanire who made the disclosure at the formal Roll Out of the COVID-19 vaccines at the National Hospital in Abuja, noted the vaccination campaign will be in four phases and will align with the planned arrival of vaccines in batches.

“The vaccines are more than enough to go round and they will be coming in phases”, he said

Ehanire further explained that each phase targets a specific segment of the eligible population to ensure equity in the vaccine deployment.

According to him, frontline health workers have been prioritised globally for vaccination against COVID-19 because of the risk involved in their jobs.

READ  Use of email no longer required for UTME, direct entry JAMB registration

“The defined frontline health care workers are prioritised globally for vaccinations against COVID-19 due to their higher exposure to the risk of COVID-19 infection in their line of duty”.

He further noted that the protection is not only for the sake of the workers but for “our sake as individuals” so they don’t become infected and absent from the place of work which will lead to short staff.

The next important group of people who if they get infected are at higher risk of severe disease are those with diabetes, obesity, chronic kidney condition, elderly people, heart disease, and other medical conditions.

The minister added that persons under 18 years and pregnant women are not allowed to take the vaccine.

“The non-eligible group should respectively await their turns, persons under 18 years and pregnant women are for now not eligible except they have been medically certified as vulnerable due to one under ailment or the other”.

READ  We have not given up on Chibok girls, release is work in progress - Presidency

The National Agency for Food and Drug Administration and Control (NAFDAC) on February 18, approved the use of the Oxford/AstraZeneca COVID-19 vaccine in Nigeria.


Leave a Reply